Long-term survival of living donor renal transplants: A single center study

Indian Journal of Nephrology

Volumn 20, Issue 4, 2010, Pages 179-184

  Hassanzadeh, J ^a   Hashiani, A A ^b   Rajaeefard, A ^a   Salahi, H ^c   Khedmati, E ^d   Kakaei, F ^e   Nikeghbalian, S ^a   Malek Hossein, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cox proportional hazard model; graft survival rate; living donor; renal transplantation

Indexed keywords

CREATININE;

ADULT; ALLOGRAFT; ARTICLE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IRAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE;

EID: 78650147755     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.73439     Document Type: Article

References (39)

1. Bosan IB. Recommendation for early diagnosis of chronic kidney disease. Ann Afr Med 2007;6:130-6.
2. Abbaszadeh S, Nourbala MH, Taheri S, Ashraf A, Einollahi B. Renal transplantation from deceased donor in Iran. Saudi J Kidney Dis Transpl 2008;19:664-8.
3. Abboud O. Incidence, prevalence and treatment of end stage renal disease in the Middle East. Ethn Dis 2006;16:S2-2-S2-4.
4. Mahdavi-Mazdeh M, Heidary Rouchi A, Norouzi S, Aghighi M, Rajolani H, Ahrabi S. Renal Replacement therapy in Iran. Urol J 2007;4:66-70.
5. Schena FP. Epidemiology of end stage renal disease: international comparisons of renal replacement therapy. Kidney Int 2000;57:39-45.
6. Hashiani AA, Rajaeefard A, Hassanzade J, Kakaei F, Behbahan AG, Nikeghbalian S, et al. Ten-year graft survival of deceased-donor kidney transplantation: A single-center experience. Ren Fail 2010;32:440-7.
7. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-12.
8. Cacho DT, Cus LI, Piqu AA, Villar PB, Reyes LI, Alvarez-Vijande Garca R, Elderly donor kidney transplant: factors involved in graft survival. Transplant Proc 2005;37:3690-992.
9. Sumboonnanonda A, Lumpaopong A, Kingwatanakul P, Tangnararatchakit K, Jiravuttipong A. Pediatric kidney transplantation in Thailand: Experience in a developing country. Transplant Proc 2008;40:2271-3.
10. Nemati E, Pourfarziani V, Jafari AM, Assari S, Moghani-Lankarani M, Khedmat H, et al. Prediction of inpatient survival and graft loss in rehospitalized kidney recipients. Transplant Proc 2007;39:974-7.
11. Parada B, Figueiredo A, Nunes P, Bastos C, Macario F, et al. Pediatric renal transplantation: comparative study with renal transplantation in the adult population. Transplant Proc 2005;37:2771-4.
12. Salehipour M, Salahi H, Jalaeian H, Bahador A, Nikeghbalian S, Barzideh E, et al. Vascular complication following 1500 consecutive living and cadaveric donor renal transplantation: A single center study. Saudi J Kidney Dis Transpl 2009;20:570-2.
13. Col PP Varma, Col AK Hooda, Col T Sinha, et al. Renal transplantation: An experience of 500 patients. Medical journal Armed Forced India 2007;63:107-11.
14. Einollahi B. Iranian experience with the non-related renal transplantation. Saudi J Kidney Dis Transpl 2004;15:421-8.
15. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al. Effect of waiting time on renal transplant out come. Kidney Int 2000;58:1311-7.
16. Shrestha BM, Haylor JL. Factors influencing long term outcome following renal transplantation: A review. J Nepal Med Assoc 2007;46:136-42.
17. Ghods AJ. Renal transplantation in Iran. Nephrol Dial transplant 2002;17:222-8.
18. Tan SY, Chen TP, Lee SH, Tan PS, Chua CT, Teo SM, et al. Cadaveric renal transplantation at university hospital Kuala Lumpur: A Preliminary report. Transplant Proc 2000;32:1811-2.
19. Courtney AE, Mcnamee PT, Maxwell AP. The evolution of renal transplantation in clinical practice: for better, for worse?. Q J Med 2008;101:967-78.
20. Mohamed AB, Mohamed AG. Living donor renal transplantation, 1976-2003: The Mansoura Experience. Saudi J Kidney Dis Transpl 2005;16:573-83.
21. Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS. Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin transplant 2008;22:263-72.
22. Briganti EM, Wolfe R, Russ GR, Eris JM, Walker RG, McNeil JJ. Graft loss following renal transplantation in Australia: Is there a center effect?. Nephrol Dial Transplant 2002;17:1099-104.
23. Feyssa E, Jones-Burton C, Ellison G, Philosophe B, Howell C. Racial/ethnic disparity in kidney transplantation outcomes: influence of donor and recipient characteristics. J Natl Med Assoc 2009;101:111-5.
24. El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, et al. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant 2005;9:763-9.
25. El-Husseini AA, Foda MA, Bakr MA, Shokeir AA, Sobh MA, Ghoneim MA. Pediatric live-donor kidney transplantation in Mansoura Urology& Nephrology Center: a 28-year perspective. Pediatr Nephrol 2006;21:1464-70.
26. Park K, Kim YS, Kim MS, Kim SI, Oh CK, Han DS, et al. A 16-year experience with1275 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival. Transplant Proc 1996;28:1578-9.
27. Kaplan B, Schold JD, Meier-Kriesche HU. Long term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol 2003;14:2980-4.
28. Meier-Kriesche HU, Oje AO, Hason JA, Kaplan B. Hepatitis C antibody status and outcome in renal transplant recipients. Transplantation 2001;72:241-4.
29. Shahbazian H, Hajiani E, Ehsanpour A. Patient and graft survival on allograft recipients with minimal hepatitis C virus infection: A case control study. Urol J 2008;5:178-83.
30. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, et al. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract 2006;102:72-80.
31. Kevin CM, Marshall MJ, Harold IF. Effect of the use or nonuse of long term dialysis on the subsequent survival of renal transplantation from living donor. N Engl J Med 2001;344:726-31.
32. Rayhill SC, D'Alessandro AM, Odorico JS, Knechtle SJ, Pirsch JD, Heisey DM, et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival?. Ann Surg 2000;231:417-23.
33. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary renal allograft recipients. Transplantation 1995;60:225.
34. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Marsh JW, McCauley J, et al. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999;67:411-5.
35. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000;69:2405-9.
36. Ciancio G, Miller J, Gonwa TA. Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation 2005;80:S191.
37. Remuzzi G, Cravedi P, Costantini M, Lesti M, Ganeva M, Gherardi G, et al. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: The MYSS follow-up randomized, controlled clinical trial. J Am Soc Nephrol 2007;18:1973-85.
38. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Gritsch HA, Fox-Hawranko L, et al. Reducing the length of stay after kidney transplantation-the intensive outpatient unit. Clin Transplant 1998;12:482-5.
39. Orsenigo E, Socci C, Carlucci M, Zuber V, Fiorina P, Gavazzi F, et al. Multivariate analysis of factors affecting patient and graft survival after renal transplant. Transplant Proc 2005;37:2461-3.